Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial

The Lancet Oncology

Volumn 18, Issue 2, 2017, Pages 259-268

  Polgár, Csaba ^a   Ott, Oliver J ^b   Hildebrandt, Guido ^c,d   Kauer Dorner, Daniela ^e   Knauerhase, Hellen ^d   Major, Tibor ^a   Lyczek, Jaroslaw ^f,g   Guinot, José Luis ^h   Dunst, Jürgen ⁱ   Miguelez, Cristina Gutierrez ^k   Slampa, Pavel ^l   Allgäuer, Michael ⁿ   Lössl, Kristina ^m   Polat, Bülent ^q   Kovács, György ^o   Fischedick, Arnt René ^p   Fietkau, Rainer ^b,d   Resch, Alexandra ^e   Kulik, Anna ^f   Arribas, Leo ^h   Niehoff, Peter ^i,j   Guedea, Ferran ^k   Schlamann, Annika ^c   Pötter, Richard ^e   Gall, Christine ^r   Uter, Wolfgang ^r   Strnad, Vratislav ^b   more..

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^e UNIVERSITY OF VIENNA   (Austria)

^f INSTITUTE OF ONCOLOGY   (Poland)

^g Podkarpacki Hospital Cancer Center Brzozow   (Poland)

^h Valencian Institute of Oncology   (Spain)

ⁱ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^j SANA KLINIKUM OFFENBACH   (Germany)

^k CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^l MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^m UNIVERSITY OF BERN   (Switzerland)

ⁿ Barmherzige Brüder Hospital   (Germany)

^o UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^p Clemenshospital Munster   (Germany)

^q UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^r UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCELERATED PARTIAL BREAST IRRADIATION; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BRACHYTHERAPY; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE SEVERITY; ESTHETICS; FAT NECROSIS; FEMALE; FOLLOW UP; HUMAN; HYPERPIGMENTATION; INTERMETHOD COMPARISON; INTERSTITIAL RADIATION; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MASTALGIA; MENOPAUSE; MIDDLE AGED; MULTICENTER STUDY; PARTIAL MASTECTOMY; PHASE 3 CLINICAL TRIAL; RADIATION DOSE; RADIATION HAZARD; RANDOMIZED CONTROLLED TRIAL; SKIN TELANGIECTASIA; SKIN TOXICITY; TELANGIECTASIA; WHOLE BREAST IRRADIATION; BREAST TUMOR; CANCER GRADING; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; LOBULAR CARCINOMA; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; RADIATION DERMATITIS; RADIOTHERAPY DOSAGE; TIME FACTOR;

COSMETIC;

AGED; BRACHYTHERAPY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; COMBINED MODALITY THERAPY; COSMETICS; FAT NECROSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RADIODERMATITIS; RADIOTHERAPY DOSAGE; TIME FACTORS;

EID: 85009384686     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(17)30011-6     Document Type: Article

References (35)

1. 1 Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005), 2087–2106.
2. 2 Bartelink, H, Maingon, P, Poortmans, P, et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol 16 (2015), 47–56.
3. 3 Yarnold, J, Bentzen, SM, Coles, C, Haviland, J, Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities. Int J Radiat Oncol Biol Phys 79 (2011), 1–9.
4. 4 Polgar, C, Van Limbergen, EV, Pötter, R, et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 94 (2010), 264–273.
5. 5 Shah, S, Vicini, F, Wazer, DE, Arthur, D, Patel, RR, The American Brachytherapy Society consensus statement for accelerated partial breast irradiation. Brachytherapy 12 (2013), 267–277.
6. 6 Smith, BD, Arthur, DW, Buchholz, TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74 (2009), 987–1001.
7. 7 Polgar, C, Major, T, Fodor, J, et al. Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol 94 (2010), 274–279.
8. 8 Shah, C, Antonucci, JV, Wilkinson, JB, et al. Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis. Radiother Oncol 100 (2011), 210–214.
9. 9 Strnad, V, Hildebrandt, G, Potter, R, et al. Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. Int J Radiat Oncol Biol Phys 80 (2011), 17–24.
10. 10 Polgar, C, Fodor, J, Major, T, Sulyok, Z, Kasler, M, Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol 108 (2013), 197–202.
11. 11 Strnad, V, Ott, OJ, Hildebrandt, G, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet 387 (2016), 229–238.
12. 12 Ott, OJ, Strnad, V, Hildebrandt, G, et al. GEC-ESTRO multicenter phase 3-trial: accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: early toxicity and patient compliance. Radiother Oncol 120 (2016), 119–123.
13. 13 Cox, JD, Stetz, J, Pajak, TF, Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995), 1341–1346.
14. 14 Lövey, K, Fodor, J, Major, T, et al. Fat necrosis after partial-breast irradiation with brachytherapy or electron irradiation versus standard whole-breast radiotherapy—4-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69 (2007), 724–731.
15. 15 Trotti, A, Colevas, AE, Setser, A, et al. CTCAE v3·0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003), 176–181.
16. 16 Harris, J, Levine, M, Svensson, G, et al. Analysis of cosmetic results following primary radiation therapy for stage I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys 5 (1979), 257–261.
17. 17 Mukesh, MB, Barnett, GC, Wilkinson, JS, et al. Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. J Clin Oncol 31 (2013), 4488–4495.
18. 18 Haviland, JS, Hopwood, P, Mills, J, Sydednham, M, Bliss, JM, Yarnold, JR, Do patient-reported outcome measures agree with clinical and photographic assessments of normal tissue effects after breast radiotherapy? The experience of the Standardisation of Breast Radiotherapy (START) trials in early breast cancer. Clin Oncol 28 (2016), 345–353.
19. 19 Chen, PY, Vicini, FA, Benitez, P, et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: A method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer 106 (2006), 991–999.
20. 20 Chafe, S, Moughan, J, McCormick, B, et al. Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: A phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer. Int J Radiat Oncol Biol Phys 86 (2013), 854–859.
21. 21 Formenti, S, Hsu, H, Fenton-Kerimian, M, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: five-year results of 100 patients. Int J Radiat Oncol Biol Phys 84 (2012), 606–611.
22. 22 Hepel, JT, Tokita, M, MacAusland, SG, et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 75 (2009), 1290–1296.
23. 23 Jagsi, R, Ben-David, MA, Moran, JM, et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 76 (2010), 71–78.
24. 24 Livi, L, Meattini, I, Marrazzo, L, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer 51 (2015), 451–463.
25. 25 Mózsa, E, Mészáros, N, Major, T, et al. Accelerated partial breast irradiation with external beam three-dimensional conformal radiotherapy: Five-year results of a prospective phase II clinical study. Strahlenther Onkol 190 (2014), 440–450.
26. 26 Olivotto, IA, Whelan, TJ, Parpia, S, et al. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol 31 (2013), 4038–4045.
27. 27 Pashtan, IM, Recht, A, Ancukiewicz, M, et al. External beam accelerated partial-breast irradiation using 32 Gy in 8 twice-daily fractions: 5-year results of a prospective study. Int J Radiat Oncol Biol Phys 84 (2012), e271–e277.
28. 28 Rodríguez, N, Sanz, X, Dengra, J, et al. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 87 (2013), 1051–1057.
29. 29 Shah, C, Wilkinson, JB, Lanni, T, et al. Five-year outcomes and toxicities using 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Clin Breast Cancer 13 (2013), 206–211.
30. 30 Vaidya, JS, Wenz, F, Bulsara, M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 383 (2014), 603–613.
31. 31 Veronesi, U, Orecchia, R, Maisonneuve, P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 14 (2013), 1269–1277.
32. 32 Hepel, J, Wazer, DE, A flawed study should not define a new standard of care. Int J Radiat Oncol Biol Phys 91 (2015), 255–257.
33. 33 Wolmark, N, Curran, WJ, Vicini, F, et al. Response to “Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation” (Int J Radiat Oncol Biol Phys 2010; 76: 71–78) and “Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation” (Int J Radiat Oncol Biol Phys 2009; 75: 1290–1296). Int J Radiat Oncol Biol Phys, 77, 2010, 317.
34. 34 Hickey, BE, Lehman, M, Francis, DP, See, AM, Partial breast irradiation for early breast cancer. Cochrane Database Syst Rev, 7, 2016 CD007077.
35. 35 Yarnold, J, Somaiah, N, Bliss, JM, Hypofractionated radiotherapy in early breast cancer: clinical, dosimetric and radio-genomic issues. Breast 24:suppl 2 (2015), S108–S113.